SAI - Detailed view

IBANDRONAT Sandoz Inj Lös 3 mg/3ml Fertspr 3 ml

Drug

Name

Ibandronat Sandoz i.v., Injektionslösung

Field of application

Osteoporose

ATC

M05BA06 - IBANDRONIC ACID

07.99.0. – various

Use

HAM – Human medicine

pharmaceutical form

LSPA – Parenteral solution

Remedy code

S – synthetic products for human use

Dispensing categories

B – Dispensed on prescription by a physician or veterinarian (B)

Authorisation status

Z – approved

Authorisation number

60532

Initial registration date

7/29/2010

Expiry date

12/31/9999

Dosage strength

Name

Ibandronat Sandoz i.v., Injektionslösung

Field of application

Osteoporose

Dosage strength number

Authorisation status

Z – approved

Package

GTIN**

7680605320012

Trade status*

In trade from / since 7/29/2010

Status

A/R – Authorised / referenced

Package size

1 syringe(s)

Package code

001

Authorisation status

Z – approved

Declaration

Component

Active substance

3 mg acidum ibandronicum
natrii ibandronas monohydricus

Excipient

acidum citricum monohydricum
natrii chloridum
natrii hydroxidum
acidum hydrochloridum concentratum
aqua ad iniectabile
12 mg natrium

Spezialitätenliste***

Status

Date of deletion

Compulsory until

Public price (CHF)

64.35

Limitation points

None

Limitation

Yes

SB Deductible

10%

Generic

Yes

Authorisation holder

GLN**

7601001029439

Address

Sandoz Pharmaceuticals AG
6343 Risch (ZG)

Date of revision of the text

4/29/2025

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.